Evidence map›Paper›PMID 31658129›Full record

ArticleThe American journal of gastroenterology2019

Delayed Gastric Emptying Associates With Diabetic Complications in Diabetic Patients With Symptoms of Gastroparesis.

Henry P Parkman, Laura A Wilson, Gianrico Farrugia, Kenneth L Koch, William L Hasler, Linda A Nguyen, Thomas L Abell, William Snape, John Clarke, Braden Kuo and 8 more

Open access · greenAbstract read
In one paragraph

Article in The American journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Cellular and molecular mechanisms underlying aging-related gastric neuromuscular dysfunction.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Association Between Visceral Fat Area and Glycated Hemoglobin in Type 2 Diabetics: A Retrospective Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Article
  15. Progress in Gastroparesis - A Narrative Review of the Work of the Gastroparesis Clinical Research Consortium.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022
    Review
  16. Article
  17. Review
  18. Disturbed gastric motility in patients with long-standing diabetes mellitus.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi · 2022
    Article
  19. Gastroparesis.Gastroenterology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 1 country.

Henry P ParkmanDepartment of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Laura A WilsonDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Gianrico FarrugiaDepartment of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Kenneth L KochDepartment of Medicine, Wake Forest University, Winston-Salem, North Carolina, USA.
William L HaslerDepartment of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Linda A NguyenDepartment of Medicine, Stanford University, Stanford, California, USA.
Thomas L AbellDepartment of Medicine, University of Louisville, Louisville, Kentucky, USA.
William SnapeDepartment of Medicine, California Pacific Medical Center, San Francisco, California, USA.
John ClarkeDepartment of Medicine, Stanford University, Stanford, California, USA.
Braden KuoDepartment of Medicine, Harvard University, Cambridge, Massachusetts, USA.
Richard W McCallumDepartment of Medicine, Texas Tech University, El-Paso, Texas, USA.
Irene SarosiekDepartment of Medicine, Texas Tech University, El-Paso, Texas, USA.
Madhusudan GroverDepartment of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Laura MirielDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
James TonasciaDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Frank A HamiltonNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Pankaj J PasrichaDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
NIDDK Gastroparesis Clinical Research Consortium (GpCRC)
Johns Hopkins Medicine · USMayo Clinic · USStanford University · USTexas Tech University · USCalifornia Pacific Medical Center · USHarvard University · USNational Institutes of Health · USTemple University · USUniversity of Louisville · USUniversity of Michigan–Ann Arbor · USWake Forest University · US

Funding

Gastroparesis Consortium Continuation-Data Coordinating CenterU01DK074008 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI TONASCIA, JAMES A · 2006 to 2015
$17.4M
PGpR2 Year 4 Supplement for the Scientific Data Research Center (SDRC) of the GpCRC 4U24DK074008 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI David M Shade · 2017 to 2026
$11.7M
Subtypes of GastroparesisU01DK073974 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Baharak Moshiree · 2006 to 2026
$7.4M
Temple University Gastroparesis Clinical CenterU01DK073975 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI HENRY PAUL PARKMAN · 2006 to 2026
$7.4M
U of L Clinical Center to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis ConsortiumU01DK074007 · NIDDK · UNIVERSITY OF MISSISSIPPI MED CTR · PI Thomas Lyman Abell · 2006 to 2026
$7.0M
Molecular Approaches to Pathogenesis/Therapy in GastropaU01DK073983 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PANKAJ J PASRICHA · 2006 to 2026
$6.8M
The GpCRC Pediatric Gastroparesis Registry 2 (PGpR2): Characterization and Clinical Course of Symptoms and Gastric Emptying in Pediatric, Adolescent, and Young Adult Participants with Symptoms of GastU01DK074035 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Irene Sarosiek · 2008 to 2026
$6.7M
New England Gastropareis Consortium: Neurobiology of GastroparesisU01DK112193 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Helen Burton Murray, Braden Kuo · 2016 to 2026
$4.8M
NIDDK NIH HHS U01 DK073974NIDDK NIH HHS U01 DK073975NIDDK NIH HHS U01 DK073983NIDDK NIH HHS U01 DK074007NIDDK NIH HHS U01 DK074008NIDDK NIH HHS U01 DK074035NIDDK NIH HHS U01 DK112193NIDDK NIH HHS U24 DK074008
6 · The paper itself

Abstract

objectivesDiabetic gastroparesis (Gp) occurs more often in type 1 diabetes mellitus (T1DM) than in type 2 diabetes mellitus (T2DM). Other diabetic end-organ complications include peripheral neuropathy, nephropathy, and retinopathy (together termed triopathy). This study determines the prevalence of diabetic complications (retinopathy, nephropathy, and peripheral neuropathy) in diabetic patients with symptoms of Gp, assessing the differences between T1DM and T2DM and delayed and normal gastric emptying (GE).

methodsDiabetic patients with symptoms of Gp underwent history and physical examination, GE scintigraphy, electrogastrography with water load, autonomic function testing, and questionnaires assessing symptoms and peripheral neuropathy.

resultsOne hundred thirty-three diabetic patients with symptoms of Gp were studied: 59 with T1DM and 74 with T2DM and 103 with delayed GE and 30 without delayed GE. The presence of retinopathy (37% vs 24%; P = 0.13), nephropathy (19% vs 11%; P = 0.22), and peripheral neuropathy (53% vs 39%; P = 0.16) was not significantly higher in T1DM than in T2DM; however, triopathies (all 3 complications together) were seen in 10% of T1DM and 3% of T2DM (P = 0.04). Diabetic patients with delayed GE had increased prevalence of retinopathy (36% vs 10%; P = 0.006) and number of diabetic complications (1.0 vs 0.5; P = 0.009); however, 39% of diabetic patients with delayed GE did not have any diabetic complications. DISCUSSION: In diabetic patients with symptoms of Gp, delayed GE was associated with the presence of retinopathy and the total number of diabetic complications. Only 10% of patients with T1DM and 3% of those with T2DM had triopathy of complications, and 39% of diabetic patients with Gp did not have any diabetic complications. Thus, the presence of diabetic complications should raise awareness for Gp in either T1DM or T2DM; however, diabetic Gp frequently occurs without other diabetic complications.

Indexed as

Diabetes ComplicationsGastric EmptyingGastroparesisCorrelation of DataDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic NeuropathiesDiabetic RetinopathyDiagnostic Techniques, Digestive SystemFemaleGlycated HemoglobinHumansMaleMiddle AgedPrevalenceSurveys and QuestionnairesGlycated Hemoglobin

Identifiers

PMID31658129
PMCPMC6832848
OpenAlexW2982556987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.